What is ethanol ablation?
Ethanol ablation, also called percutaneous ethanol injection, places medical-grade alcohol into a thyroid cyst under ultrasound guidance. The ethanol damages the lining of the treated cavity, which can promote scarring and reduce fluid reaccumulation.
It is different from radioactive iodine treatment and from thermal ablation methods such as radiofrequency ablation.
Who might qualify?
Ethanol ablation is best established for selected benign pure cysts or predominantly cystic thyroid nodules that return after drainage and cause pressure symptoms or cosmetic concern.
It is not a general treatment for every thyroid nodule. Solid nodules, nodules with suspicious ultrasound findings, and nodules that have not been adequately confirmed as benign require a different evaluation.
A nonfunctioning appearance on a nuclear scan does not prove that a nodule is benign and does not determine whether ethanol ablation is appropriate. Current evaluation relies on ultrasound, clinical findings, thyroid testing, and biopsy when indicated.
Is ethanol ablation used for thyroid cancer?
In selected cases, percutaneous ethanol ablation may be considered for recurrent or residual differentiated thyroid cancer in a cervical lymph node. This is a different use from treating a benign thyroid cyst and requires a thyroid cancer team to evaluate the full extent of disease.
The 2025 American Thyroid Association guideline describes ethanol ablation as a conditional, low-certainty alternative with greatest use in patients at high risk for complications from another operation. It should not be presented as routine treatment for every cancer-involved lymph node.
The target should generally be confirmed as cancer, carefully localized, and suitable for focused treatment. Depending on the disease, reasonable options may include active surveillance, reoperation, another local treatment such as radiofrequency ablation, or additional cancer therapy.
For broader context, read the thyroid cancer guide.
What evaluation is needed first?
- Diagnostic ultrasound to confirm the cystic composition and examine nearby structures
- Appropriate benign cytology or other benign confirmation based on the nodule's features
- Review of symptoms, prior drainage, growth, thyroid function, and treatment goals
- Review of medicines, bleeding risk, allergies, and relevant medical conditions
- Discussion of monitoring, repeat aspiration, ethanol ablation, thermal ablation, and surgery
Do not stop a prescribed medicine unless the treating or prescribing clinician gives specific instructions.
What happens during treatment?
The patient is positioned for ultrasound examination, and the skin is cleaned. Local anesthetic may be used. Under continuous ultrasound guidance, a needle is placed into the cyst, fluid is removed, and a controlled amount of ethanol is introduced.
Technique and observation time vary. The procedure should be performed by a clinician trained in thyroid ultrasound and ablation, with a plan for recognizing and managing complications.
What are the potential benefits and limitations?
Ethanol ablation can substantially reduce the volume of an appropriately selected cyst and improve pressure or cosmetic symptoms without thyroid surgery. It is generally less suitable for nodules with a large solid component.
The cyst may not shrink enough, fluid may return, and more than one treatment may be needed. Persistent symptoms, regrowth, or concerning findings can lead to another biopsy, a different ablation method, or surgery.
What are the risks and recovery considerations?
Temporary pain or burning is common during or shortly after injection. Other possible complications include bruising, bleeding, ethanol leakage into nearby tissue, infection, and temporary or persistent voice change from nerve irritation or injury.
The treating facility should provide instructions about activity, medicines, discomfort, and urgent symptoms. Promptly report expanding neck swelling, trouble breathing or swallowing, persistent bleeding, fever, worsening pain, or a new voice change.
What follow-up is needed?
Follow-up commonly includes symptom review and ultrasound to measure the treated nodule. The schedule depends on the clinical situation and the facility's protocol.
Further treatment may be discussed if symptoms persist, the cyst refills, a solid component remains clinically important, or new concerning findings appear.
Questions to ask the treating clinician
- Has the nodule been adequately confirmed as benign?
- How much of the nodule is cystic?
- Why is ethanol ablation preferable to another aspiration or monitoring?
- Would radiofrequency ablation or surgery be more appropriate?
- How much experience do you have with thyroid ethanol ablation?
- What complications should I watch for?
- How will response and possible regrowth be monitored?
- If cancer treatment is being discussed, has the target been confirmed and reviewed by a multidisciplinary thyroid cancer team?
Sources and medical review
Medically reviewed by Richard B. Guttler, MD, FACP, FACE, ECNU · September 2026
Dr. Guttler's 2010 videos show ultrasound-guided FNA, ethanol injection into a thyroid cyst, and percutaneous ethanol injection for selected cervical cancer nodes. They are treated as historical procedural context, not as current training or individualized treatment guidance. The videos are not embedded because patient identity and publication consent have not been verified.
- American Thyroid Association: General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules, 2023
- American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer, 2025
- European Thyroid Association Clinical Practice Guideline for Image-Guided Ablation in Benign Thyroid Nodules, 2020
- European Guideline for Minimally Invasive Treatments in Malignant Thyroid Lesions, 2021
- Korean Society of Thyroid Radiology Consensus Statement on Ethanol Ablation, 2018
- Dr. Richard B. Guttler: Ultrasound Guided FNA Biopsy of Cold Thyroid Nodule and Ethanol Injection Technique, 2010
- Dr. Richard B. Guttler: P.E.I. Treatments for Thyroid Cysts and Cancer Lymph Nodes, 2010